Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 4:39 PM View:  | Gala Renee D President & COO | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Apr-24 | Payment of Exercise | 1,736 | $115.21 | $200,005.00 | (3%) 57.09K to 55.36K | |
| 08-Mar-24 6:07 PM View: | Carr Patricia SVP, Chief Accounting Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 07-Mar-24 | Sale | 1,768 | $116.98 | $206,821.00 | (21%) 8.36K to 6.6K | |
| 08-Mar-24 6:07 PM View: | Carr Patricia SVP, Chief Accounting Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 06-Mar-24 | Sale | 1,936 | $119.64 | $231,628.00 | (19%) 10.3K to 8.36K | |
| 07-Mar-24 9:47 PM View: | Iannone Robert EVP, Global Head of R&D | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-24 | Payment of Exercise | 4,294 | $117.53 | $504,674.00 | (6%) 66.52K to 62.23K | |
| 07-Mar-24 9:53 PM View: | Gala Renee D President & COO | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-24 | Payment of Exercise | 3,622 | $117.53 | $425,694.00 | (6%) 60.72K to 57.09K | |
| 07-Mar-24 9:44 PM View: | Cozadd Bruce C Chairman & CEO Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-24 | Payment of Exercise | 22,436 | $117.53 | $2,636,900.00 | (5%) 452.25K to 429.81K | |
| 07-Mar-24 9:49 PM View: | Pearce Samantha SVP, Head of Europe & Internat | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-24 | Payment of Exercise | 2,474 | $117.53 | $290,769.00 | (13%) 19.4K to 16.92K | |
| 07-Mar-24 9:48 PM View: | Patil Neena M EVP & Chief Legal Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-24 | Payment of Exercise | 3,432 | $117.53 | $403,363.00 | (8%) 45.06K to 41.63K | |
| 05-Mar-24 7:52 PM View: | Pearce Samantha SVP, Head of Europe & Internat | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 5,065 | -- | -- | 35% 14.33K to 19.4K | |
| 05-Mar-24 7:32 PM View: | Kennedy Patrick Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 1,423 | -- | -- | 100% 0 to 1.42K | |
| 05-Mar-24 7:50 PM View: | Patil Neena M EVP & Chief Legal Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 12,348 | -- | -- | 38% 32.71K to 45.06K | |
| 05-Mar-24 7:47 PM View: | Iannone Robert EVP, Global Head of R&D | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 16,928 | -- | -- | 34% 49.59K to 66.52K | |
| 05-Mar-24 7:28 PM View: | Johnson Philip L EVP & Chief Financial Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 15,932 | -- | -- | 100% 0 to 15.93K | |
| 05-Mar-24 7:54 PM View: | Carr Patricia SVP, Chief Accounting Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 2,987 | -- | -- | 41% 7.31K to 10.3K | |
| 05-Mar-24 7:58 PM View: | Henderson Mary Elizabeth SVP, Technical Operations | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 5,178 | -- | -- | 48% 10.76K to 15.94K | |
| 05-Mar-24 7:44 PM View: | Gala Renee D President & COO | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 19,916 | -- | -- | 49% 40.8K to 60.72K | |
| 05-Mar-24 7:28 PM View: | Johnson Philip L EVP & Chief Financial Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Purchase | 12,000 | $119.65 | $1,435,800.00 | 75% 15.93K to 27.93K | |
| 05-Mar-24 7:34 PM View: | Cozadd Bruce C Chairman & CEO Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 50,187 | -- | -- | 12% 402.06K to 452.25K | |
| 19-Jan-24 6:23 PM View: | Gala Renee D President & COO | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Payment of Exercise | 3,204 | $119.13 | $381,692.00 | (7%) 44.0K to 40.8K | |
| 19-Jan-24 6:25 PM View: | Iannone Robert EVP, Global Head of R&D | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Grant | 5,970 | -- | -- | 13% 45.35K to 51.32K | |
| 19-Jan-24 6:21 PM View: | Cozadd Bruce C Chairman & CEO Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Payment of Exercise | 12,245 | $119.13 | $1,458,750.00 | (3%) 414.3K to 402.06K | |
| 19-Jan-24 6:19 PM View: | Carr Patricia SVP, Chief Accounting Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Grant | 1,327 | -- | -- | 22% 6.04K to 7.36K | |
| 19-Jan-24 6:23 PM View: | Gala Renee D President & COO | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Grant | 7,079 | -- | -- | 19% 36.92K to 44.0K | |
| 19-Jan-24 6:33 PM View: | Pearce Samantha SVP, Head of Europe & Internat | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Payment of Exercise | 1,038 | $119.13 | $123,657.00 | (7%) 15.37K to 14.33K | |
| 19-Jan-24 6:21 PM View: | Cozadd Bruce C Chairman & CEO Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Grant | 26,545 | -- | -- | 7% 387.76K to 414.3K | |
| 19-Jan-24 6:28 PM View: | Patil Neena M EVP & Chief Legal Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Payment of Exercise | 1,656 | $119.13 | $197,279.00 | (5%) 34.37K to 32.71K | |
| 19-Jan-24 6:33 PM View: | Pearce Samantha SVP, Head of Europe & Internat | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Grant | 2,210 | -- | -- | 17% 13.16K to 15.37K | |
| 19-Jan-24 6:25 PM View: | Iannone Robert EVP, Global Head of R&D | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Payment of Exercise | 1,730 | $119.13 | $206,095.00 | (3%) 51.32K to 49.59K | |
| 19-Jan-24 6:28 PM View: | Patil Neena M EVP & Chief Legal Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Grant | 5,087 | -- | -- | 17% 29.28K to 34.37K | |
| 06-Dec-23 4:31 PM View: | Cook Jennifer E. Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 04-Dec-23 | Sale | 417 | $119.27 | $49,735.60 | (6%) 7.3K to 6.89K | |
| 06-Dec-23 4:39 PM View: | Smith Mark Douglas Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 04-Dec-23 | Sale | 417 | $119.27 | $49,735.60 | (6%) 7.3K to 6.89K | |
| 12-Feb-24 10:00 PM View: | Carr Patricia SVP, Chief Accounting Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 04-Dec-23 | Sale | 50 | $121.39 | $6,069.73 | (< 1%) 6.04K to 5.99K | |
| 14-Nov-23 10:00 PM View: | Gala Renee D President & COO | Jazz Pharmaceuticals, Inc. (JAZZ) | 10-Nov-23 | Grant | 772 | -- | -- | 2% 36.12K to 36.89K | |
| 06-Sep-23 5:09 PM View: | Patil Neena M EVP & Chief Legal Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Sep-23 | Market Sale (Planned) | 1,500 | $144.25 | $216,375.00 | (5%) 30.69K to 29.19K | (2%) |
| 31-Aug-23 6:44 PM View: | Carr Patricia SVP, Chief Accounting Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 29-Aug-23 | Market Sale | 142 | $143.47 | $20,372.50 | (2%) 6.13K to 5.99K | (2%) |
| 17-Aug-23 5:21 PM View: | Patil Neena M EVP & Chief Legal Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 15-Aug-23 | Market Sale | 750 | $139.59 | $104,695.00 | (2%) 31.44K to 30.69K | (5%) |
| 15-Aug-23 7:51 PM View: | Oriordan Anne Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,454.00 | (9%) 13.79K to 12.55K | |
| 15-Aug-23 5:44 PM View: | Cook Jennifer E. Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,454.00 | (15%) 8.55K to 7.3K | |
| 15-Aug-23 6:00 PM View: | Smith Mark Douglas Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,454.00 | (15%) 8.55K to 7.3K | |
| 15-Aug-23 7:49 PM View: | O'Keefe Kenneth W Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,455.00 | (4%) 30.41K to 29.17K | |
| 15-Aug-23 5:58 PM View: | Riedel Norbert G Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,454.00 | (8%) 14.95K to 13.71K | |
| 15-Aug-23 5:43 PM View: | Carr Patricia SVP, Chief Accounting Officer | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Market Sale | 158 | $138.16 | $21,828.90 | (3%) 6.29K to 6.13K | (6%) |
| 15-Aug-23 6:02 PM View: | Sohn Catherine A. Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,455.00 | (8%) 16.11K to 14.87K | |
| 15-Aug-23 5:45 PM View: | Enright Patrick G Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,455.00 | (6%) 22.19K to 20.95K | |
| 15-Aug-23 5:47 PM View: | Gray Peter Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,455.00 | (7%) 17.31K to 16.07K | |
| 15-Aug-23 5:52 PM View: | McSharry Heather Ann Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,344 | $138.16 | $185,685.00 | (7%) 18.12K to 16.78K | |
| 15-Aug-23 6:08 PM View: | Winningham Rick E Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,455.00 | (11%) 11.69K to 10.44K | |
| 15-Aug-23 7:49 PM View: | O'Keefe Kenneth W Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-23 | Grant | 3,075 | -- | -- | 11% 27.33K to 30.41K | |
| 15-Aug-23 5:58 PM View: | Riedel Norbert G Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-23 | Grant | 3,075 | -- | -- | 26% 11.87K to 14.95K | |
| 15-Aug-23 6:02 PM View: | Sohn Catherine A. Director | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-23 | Grant | 3,075 | -- | -- | 24% 13.03K to 16.11K |
